Increased prevalence of metabolic syndrome in patients with bipolar disorder compared to a selected control group-a Northern Netherlands LifeLines population cohort study
OBJECTIVES: Metabolic syndrome (MetS) is highly prevalent among patients with bipolar disorder (BD). The aims of this cross-sectional study were to determine the prevalence of MetS in Dutch BD subjects and compare it with a control group, to examine the association of demographic and clinical characteristics with MetS in BD, and to determine the extent to which metabolic dysregulation is treated in those patients. METHODS: 493 Dutch adult patients (≥ 18 years) with BD receiving psychotropic drugs and 493 matched control subjects were compared using data from the biobank Lifelines. We determine... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2021 |
Reihe/Periodikum: | Schuster , M P , Borkent , J , Chrispijn , M , Ioannou , M , Doornbos , B , Burger , H & Haarman , B C M 2021 , ' Increased prevalence of metabolic syndrome in patients with bipolar disorder compared to a selected control group-a Northern Netherlands LifeLines population cohort study ' , Journal of Affective Disorders , vol. 295 , pp. 1161-1168 . https://doi.org/10.1016/j.jad.2021.08.139 |
Schlagwörter: | Bipolar disorder / Comorbidity / Metabolic syndrome / Psychotropic drugs / Antidepressive agents / Smoking / RISK / ANTIDEPRESSANTS / ANTIPSYCHOTICS / METAANALYSIS / WEIGHT / HEALTH |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26824491 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/0ee8a87a-5f0e-4e56-b4ca-11ae030dd3f4 |